- Drug Pipelines
- April 2024
- 50 Pages
Global
From €1446EUR$1,500USD£1,237GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1205EUR$1,250USD£1,031GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1205EUR$1,250USD£1,031GBP
- Drug Pipelines
- April 2024
- 40 Pages
Global
From €1205EUR$1,250USD£1,031GBP
- Drug Pipelines
- April 2024
- 40 Pages
Global
From €1205EUR$1,250USD£1,031GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1205EUR$1,250USD£1,031GBP
- Report
- February 2024
- 150 Pages
Global
From €7665EUR$7,950USD£6,555GBP
- Report
- February 2024
- 75 Pages
Global
From €3808EUR$3,950USD£3,257GBP
- Report
- May 2023
- 186 Pages
Global
From €3071EUR$3,185USD£2,626GBP
€4387EUR$4,550USD£3,752GBP
- Report
- May 2023
- 186 Pages
Global
From €3071EUR$3,185USD£2,626GBP
€4387EUR$4,550USD£3,752GBP
- Report
- December 2023
- 173 Pages
Global
From €2410EUR$2,500USD£2,061GBP
- Report
- December 2020
- 66 Pages
Global
From €819EUR$850USD£701GBP
- Report
- December 2018
- 180 Pages
Global
From €1340EUR$1,390USD£1,146GBP
- Report
- February 2022
- 197 Pages
Global
From €3071EUR$3,185USD£2,626GBP
€4387EUR$4,550USD£3,752GBP
- Report
- April 2023
- 135 Pages
Global
From €4579EUR$4,750USD£3,917GBP
- Report
- August 2022
- 141 Pages
Global
From €4579EUR$4,750USD£3,917GBP
- Report
- April 2023
- 180 Pages
Global
From €7231EUR$7,500USD£6,184GBP
- Report
- April 2023
- 114 Pages
Global
From €4579EUR$4,750USD£3,917GBP
- Report
- August 2022
- 117 Pages
Global
From €4338EUR$4,500USD£3,710GBP
- Report
- September 2021
- 110 Pages
Global
From €4338EUR$4,500USD£3,710GBP
The Botulinum Toxin market is a subset of the biotechnology industry that focuses on the production and sale of botulinum toxin, a neurotoxin produced by the bacterium Clostridium botulinum. Botulinum toxin is used in a variety of medical and cosmetic applications, including the treatment of muscle spasms, wrinkles, and excessive sweating. It is also used to treat a variety of neurological disorders, such as dystonia and blepharospasm.
The Botulinum Toxin market is highly competitive, with a number of companies offering products for both medical and cosmetic applications. Companies in the market include Allergan, Ipsen, Merz, Revance Therapeutics, and Galderma. These companies are engaged in research and development, manufacturing, and marketing of botulinum toxin products. Additionally, there are a number of smaller companies that specialize in the production of botulinum toxin for specific applications. Show Less Read more